{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:35:09Z","timestamp":1769114109000,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T00:00:00Z","timestamp":1213660800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1745-6215-9-37","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T05:34:35Z","timestamp":1336541675000},"source":"Crossref","is-referenced-by-count":90,"title":["The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke"],"prefix":"10.1186","volume":"9","author":[{"name":"the IST-3 collaborative group","sequence":"first","affiliation":[]},{"given":"Peter","family":"Sandercock","sequence":"first","affiliation":[]},{"given":"Richard","family":"Lindley","sequence":"additional","affiliation":[]},{"given":"Joanna","family":"Wardlaw","sequence":"additional","affiliation":[]},{"given":"Martin","family":"Dennis","sequence":"additional","affiliation":[]},{"given":"Steff","family":"Lewis","sequence":"additional","affiliation":[]},{"given":"Graham","family":"Venables","sequence":"additional","affiliation":[]},{"given":"Adam","family":"Kobayashi","sequence":"additional","affiliation":[]},{"given":"Anna","family":"Czlonkowska","sequence":"additional","affiliation":[]},{"given":"Eivind","family":"Berge","sequence":"additional","affiliation":[]},{"given":"Karsten Bruins","family":"Slot","sequence":"additional","affiliation":[]},{"given":"Veronica","family":"Murray","sequence":"additional","affiliation":[]},{"given":"Andre","family":"Peeters","sequence":"additional","affiliation":[]},{"given":"Graeme","family":"Hankey","sequence":"additional","affiliation":[]},{"given":"Karl","family":"Matz","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Brainin","sequence":"additional","affiliation":[]},{"given":"Stefano","family":"Ricci","sequence":"additional","affiliation":[]},{"given":"Maria Grazia","family":"Celani","sequence":"additional","affiliation":[]},{"given":"Enrico","family":"Righetti","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Cantisani","sequence":"additional","affiliation":[]},{"given":"Gord","family":"Gubitz","sequence":"additional","affiliation":[]},{"given":"Steve","family":"Phillips","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Arauz","sequence":"additional","affiliation":[]},{"given":"Kameshwar","family":"Prasad","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Correia","sequence":"additional","affiliation":[]},{"given":"Phillippe","family":"Lyrer","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,6,17]]},"reference":[{"key":"250_CR1","volume-title":"The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020","author":"CJL Murray","year":"1996","unstructured":"Murray CJL, Lopez AD: The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. 1996, Boston: Harvard University Press"},{"key":"250_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000107983","volume":"6","author":"K Asplund","year":"1996","unstructured":"Asplund K: Stroke in Europe: widening gap between East and West. Cerebrovascular Diseases. 1996, 6: 3-6. 10.1159\/000107983.","journal-title":"Cerebrovascular Diseases"},{"key":"250_CR3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","volume":"31","author":"ZM Chen","year":"2000","unstructured":"Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, Xie JX, Warlow C, Peto R: On behalf of the CAST and IST collaborative groups. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the international stroke trial. Stroke. 2000, 31: 1240-9.","journal-title":"Stroke"},{"issue":"24","key":"250_CR4","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"The National Institute of Stroke and Neurological Disorders rt-PA Stroke Study Group","year":"1995","unstructured":"The National Institute of Stroke and Neurological Disorders rt-PA Stroke Study Group: Tissue Plasminogen Activator for Acute Ischemic Stroke. NEJM. 1995, 333 (24): 1581-7. 10.1056\/NEJM199512143332401.","journal-title":"NEJM"},{"issue":"13","key":"250_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","volume":"274","author":"W Hacke","year":"1995","unstructured":"Hacke W, Kaste M, Fieschi C, Danilo T, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne M: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995, 274 (13): 1017-25. 10.1001\/jama.274.13.1017.","journal-title":"JAMA"},{"key":"250_CR6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, ez-Tejedor E, Trouillas P: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998, 352: 1245-51. 10.1016\/S0140-6736(98)08020-9.","journal-title":"Lancet"},{"key":"250_CR7","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","volume":"282","author":"WM Clark","year":"1999","unstructured":"Clark WM, Wissoman S, Hamandas JH, Albers GW, Madden KP, Hamilton S: Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. JAMA. 1999, 282: 2019-26. 10.1001\/jama.282.21.2019.","journal-title":"JAMA"},{"issue":"1","key":"250_CR8","first-page":"307","volume":"31","author":"GW Albers","year":"2000","unstructured":"Albers GW, Clark WM, Madden KP, Hamilton SA: The ATLANTIS T-PA Acute Stroke Trial: results for patients treated within three hours of stroke onset. Stroke. 2000, 31 (1): 307-","journal-title":"Stroke"},{"key":"250_CR9","doi-asserted-by":"crossref","unstructured":"Wardlaw JM, del Zoppo G, Yamaguchi T, Berge E: Thrombolysis for acute ischaemic stroke (Cochrane Review). The Cochrane Library. 2003, Oxford, Update Software, 3","DOI":"10.1002\/14651858.CD000213"},{"key":"250_CR10","doi-asserted-by":"crossref","unstructured":"Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta J, Haley E, Kwiatkowski T, Levine S, Lewandowski C, Lu M, Lyden P, Marler J, Patel S, Tilley B, Albers G, Bluhmki E, Wilhelm M, Hamilton S: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 363: 768-74. 2004 March 6","DOI":"10.1016\/S0140-6736(04)15692-4"},{"issue":"Suppl 1","key":"250_CR11","first-page":"126","volume":"9","author":"GW Albers","year":"1999","unstructured":"Albers GW, Clark WM, for the ATLANTIS Study Investigators: The ATLANTIS rt-PA (Alteplase) acute stroke trial: final results. Cerebrovascular Diseases. 1999, 9 (Suppl 1): 126-","journal-title":"Cerebrovascular Diseases"},{"key":"250_CR12","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1161\/str.32.11.2710","volume":"32","author":"G Donnan","year":"2001","unstructured":"Donnan G, Davis SM: When is enough enough?. Stroke. 2001, 32: 2710-2711.","journal-title":"Stroke"},{"key":"250_CR13","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/str.32.11.2708","volume":"32","author":"R Lindley","year":"2001","unstructured":"Lindley R: Further Randomized Controlled Trials of Tissue Plasminogen Activator Within 3 Hours Are Required. Stroke. 2001, 32: 2708-2709.","journal-title":"Stroke"},{"key":"250_CR14","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1161\/01.STR.32.6.1310","volume":"32","author":"P Lyden","year":"2001","unstructured":"Lyden P: Further randomized controlled trials of tPA within 3 hours are required-NOT. Stroke. 2001, 32: 2708-2709.","journal-title":"Stroke"},{"key":"250_CR15","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/01.STR.32.8.1832","volume":"32","author":"SD Reed","year":"2001","unstructured":"Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JJ: Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001, 32: 1832-40.","journal-title":"Stroke"},{"key":"250_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/01.STR.32.5.1061","volume":"32","author":"S Johnston","year":"2001","unstructured":"Johnston S, Fung L, Gillum L, Smith W, Brass L, Lichtman J, Brown A: Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic centers. The influence of ethnicity. Stroke. 2001, 32: 1061-8. 10.1161\/hs1201.099631.","journal-title":"Stroke"},{"issue":"2","key":"250_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/archneur.55.2.155","volume":"55","author":"SH Horowitz","year":"1998","unstructured":"Horowitz SH: Thrombolytic therapy in acute stroke: neurologists, get off your hands! [see comments]. Archives of Neurology. 1998, 55 (2): 155-7. 10.1001\/archneur.55.2.155.","journal-title":"Archives of Neurology"},{"key":"250_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(03)00343-0","volume":"2","author":"M Kaste","year":"2003","unstructured":"Kaste M: Approval of alteplase in Europe: will it change stroke management?. Lancet Neurology. 2003, 2: 207-208. 10.1016\/S1474-4422(03)00343-0.","journal-title":"Lancet Neurology"},{"key":"250_CR19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1017\/S148180350000508X","volume":"3","author":"Canadian Association of Emergency Physicians Committee on Thrombolytic Therapy for Acute Ischemic Stroke","year":"2001","unstructured":"Canadian Association of Emergency Physicians Committee on Thrombolytic Therapy for Acute Ischemic Stroke: Thrombolytic therapy for acute ischemic stroke. Canadian Journal of Emergency Medicine. 2001, 3: 8-12.","journal-title":"Canadian Journal of Emergency Medicine"},{"key":"250_CR20","volume-title":"American Academy of Emergency Physicians position statement on the use of intravenous thrombolytic therapy in the treatment of stroke","author":"DG Goyal","year":"2003","unstructured":"Goyal DG, Li J, Mann J, Schriger DL: American Academy of Emergency Physicians position statement on the use of intravenous thrombolytic therapy in the treatment of stroke. 2003, http:\/\/www.aaem.org\/positionstatements\/thrombolytictherapy.php"},{"key":"250_CR21","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJM199710303371812","volume":"337","author":"L Caplan","year":"1997","unstructured":"Caplan L, Mohr JP, Kistler JP, Koroshetz W, Grotta J: Clinical Debate: Should thrombolytic therapy be the first-line treatment for acute ischaemic stroke?. New England Journal of Medicine. 1997, 337: 1309-1313. 10.1056\/NEJM199710303371812.","journal-title":"New England Journal of Medicine"},{"key":"250_CR22","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/01.STR.0000064841.47697.22","volume":"34","author":"HP Adams","year":"2003","unstructured":"Adams HP, Adams RJ, Brott T, del Zoppo G, Furlan AJ, Goldstein LB, Grubb RL, Higashida R, Kidwell CS, Kwiatkowski T, Marler J, Hademenos GJ: Guidelines for the Early Management of Patients With Ischemic Stroke. A Scientific Statement From the Stroke Council of the American Stroke Association. Stroke. 2003, 34: 1056-1083. 10.1161\/01.STR.0000064841.47697.22.","journal-title":"Stroke"},{"key":"250_CR23","doi-asserted-by":"crossref","unstructured":"Sandercock P, Berge E, Dennis M, Hand P, Kwan J, Lewis S, Neilson AR, Lindley R, Thomas B, Wardlaw JM: A systematic review of the effectiveness, cost-effectiveness and barriers to the implementation of thrombolytic and neuroprotective treatment in the NHS. Health Technology Assessment. 2002, 6 (26):","DOI":"10.3310\/hta6260"},{"key":"250_CR24","volume-title":"National Clinical Guidelines for Stroke Update 2002","author":"Intercollegiate Working Party for Stroke","year":"2002","unstructured":"Intercollegiate Working Party for Stroke: National Clinical Guidelines for Stroke Update 2002. 2002, London, Royal College of Physicians"},{"issue":"5","key":"250_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/ageing\/31.5.365","volume":"31","author":"P Langhorne","year":"2002","unstructured":"Langhorne P, Pollock A: What are the components of effective stroke unit care?. Age & Ageing. 2002, 31 (5): 365-371. 10.1093\/ageing\/31.5.365.","journal-title":"Age & Ageing"},{"key":"250_CR26","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1161\/01.STR.0000014509.11540.66","volume":"33","author":"J Leonardi-Bee","year":"2002","unstructured":"Leonardi-Bee J, Bath PM, Phillips S, Sandercock P, International Stroke Trial Collaborative Group: Blood Pressure and Clinical Outcomes in the International Stroke Trial. Stroke. 2002, 33: 1315-1320. 10.1161\/01.STR.0000014509.11540.66.","journal-title":"Stroke"},{"key":"250_CR27","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1161\/01.CIR.0000012747.53592.6A","volume":"105","author":"D Tanne","year":"2002","unstructured":"Tanne D, Kasner ES, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine S, Multicenter rt-PA Stroke Survey Group: Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice. The multicenter rt-PA acute stroke survey. Circulation. 2002, 105: 1679-1685. 10.1161\/01.CIR.0000012747.53592.6A.","journal-title":"Circulation"},{"key":"250_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1474-4422(03)00412-5","volume":"2","author":"A Ciccone","year":"2003","unstructured":"Ciccone A: Consent to thrombolysis in acute ischaemic stroke: from trial to practice. Lancet Neurology. 2003, 2: 375-378. 10.1016\/S1474-4422(03)00412-5.","journal-title":"Lancet Neurology"},{"key":"250_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/bmj.325.7361.415","volume":"325","author":"L Koops","year":"2002","unstructured":"Koops L, Lindley R: Thrombolysis for acute ischaemic stroke: consumer involvement in the design of new randomised controlled trial. British Medical Journal. 2002, 325: 415-417. 10.1136\/bmj.325.7361.415.","journal-title":"British Medical Journal"},{"key":"250_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/cpt1974155443","volume":"15","author":"DR Taves","year":"1974","unstructured":"Taves DR: Minimization: a new method for assigning patients to treatment and control groups. Clinical Pharmacology and therapeutics. 1974, 15: 443-453.","journal-title":"Clinical Pharmacology and therapeutics"},{"key":"250_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/hs0402.105909","volume":"33","author":"C Counsell","year":"2002","unstructured":"Counsell C, Dennis M, McDowall M, Warlow C: Predicting outcome after acute and subacute stroke. Development and validation of new prognostic models. Stroke. 2002, 33: 1041-1047. 10.1161\/hs0402.105909.","journal-title":"Stroke"},{"key":"250_CR32","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1161\/01.STR.29.8.1504","volume":"29","author":"T Brott","year":"1998","unstructured":"Brott T, Lu M, Kothari R, Fagan S, Frankel M, Grotta J: Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke. 1998, 29: 1504-1509.","journal-title":"Stroke"},{"key":"250_CR33","unstructured":"Blood pressure in Acute Stroke Collaboration: Vasoactive drugs for acute stroke. Cochrane Library. 2003, Oxford: Update Software, 2"},{"issue":"4","key":"250_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/00004872-200304000-00003","volume":"21","author":"PM Bath","year":"2003","unstructured":"Bath PM, Chalmers J, Powers W, Beilin LJ, Davis S, Lenfant C, Mancia C, Neal B, Whitworth J, International Society of Hypertension Writing Group: International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. Journal of Hypertension. 2003, 21 (4): 665-672. 10.1097\/00004872-200304000-00003.","journal-title":"Journal of Hypertension"},{"issue":"3","key":"250_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00001721-199505000-00012","volume":"6","author":"C Ludlam","year":"1995","unstructured":"Ludlam C, Bennett B, Fox KA, Lowe G, Reid A: Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for standards in Haematology. Blood Coagul Fibrinolysis. 1995, 6 (3): 273-285. 10.1097\/00001721-199505000-00012.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"250_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000205234","volume":"17","author":"A von Clauss","year":"1957","unstructured":"von Clauss A: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957, 17: 237-246.","journal-title":"Acta Haematol"},{"key":"250_CR37","first-page":"1281","volume":"162","author":"MD Hill","year":"2000","unstructured":"Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM: Anaphylactoid reactions and angioedema during alteplase treatment of acute stroke. CMAJ. 2000, 162: 1281-1284.","journal-title":"CMAJ"},{"key":"250_CR38","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S0140-6736(95)92049-8","volume":"346","author":"Multicentre Acute Stroke Trial Italy (MAST-I) Group","year":"1995","unstructured":"Multicentre Acute Stroke Trial Italy (MAST-I) Group: Randomised controlled trial of streptokinase, aspirin, & combination of both in treatment of acute ischaemic stroke. Lancet. 1995, 346: 1509-14.","journal-title":"Lancet"},{"key":"250_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","unstructured":"Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high-risk patients. BMJ. 2002, 324: 71-86. 10.1136\/bmj.324.7336.S71.","journal-title":"BMJ"},{"key":"250_CR40","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/01.STR.20.6.828","volume":"20","author":"JM Bamford","year":"1989","unstructured":"Bamford JM, Sandercock P, Warlow C, Slattery J: Interobserver Agreement for the Assessment of Handicap in Stroke Patients. Stroke. 1989, 20: 828-828.","journal-title":"Stroke"},{"key":"250_CR41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000108501","volume":"4","author":"R Lindley","year":"1994","unstructured":"Lindley R, Waddell F, Livingstone M, Warlow C, Dennis M, Sandercock P: Can simple questions assess outcome after stroke?. Cerebrovasc Dis. 1994, 4: 314-324. 10.1159\/000108501.","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"250_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/jnnp.69.4.487","volume":"69","author":"P Dorman","year":"2000","unstructured":"Dorman P, Dennis MS, Sandercock P: Are the modified \"simple questions\" a valid and reliable measure of health related quality of life after stroke?. J Neurol Neurosurg Psychiatry. 2000, 69 (4): 487-93. 10.1136\/jnnp.69.4.487.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"250_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/bmj.315.7106.461","volume":"315","author":"P Dorman","year":"1997","unstructured":"Dorman P, Slattery J, Farrell B, Dennis M, Sandercock P, United Kingdom collaborators in the International Stroke Trial: A randomised comparison of the EuroQol and Short Form-36 after stroke. British Medical Journal. 1997, 315: 461-461.","journal-title":"British Medical Journal"},{"key":"250_CR44","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/0140-6736(91)93206-O","volume":"337","author":"JM Bamford","year":"1991","unstructured":"Bamford JM, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991, 337: 1521-1526. 10.1016\/0140-6736(91)93206-O.","journal-title":"Lancet"},{"key":"250_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R, Pike M, Armitage P, Breslow N, Cox D, Howard S: Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. analysis and examples. British Journal of Cancer. 1977, 35: 1-39.","journal-title":"British Journal of Cancer"},{"key":"250_CR46","volume-title":"MRC Guidelines for Good Clinical Practice in Clinical Trials","author":"MRC Clinical Trials Series","year":"1998","unstructured":"MRC Clinical Trials Series: MRC Guidelines for Good Clinical Practice in Clinical Trials. 1998, London: Medical Research Council"},{"key":"250_CR47","unstructured":"The Safe Implementation of Thrombolysis in Stroke (SITS) website. accessed on 27 May 2003, http:\/\/www.acutestroke.org"},{"key":"250_CR48","unstructured":"The Third International Stroke Trial (IST-3) website. http:\/\/www.ist3.com"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-9-37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-9-37\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-9-37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T11:44:38Z","timestamp":1687434278000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-9-37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,17]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["250"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-9-37","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,17]]},"article-number":"37"}}